BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 20555140)

  • 1. Behavioral effects induced by mitochondria-targeted antioxidant SkQ1 in Wistar and senescence-accelerated OXYS rats.
    Stefanova NA; Fursova AZh; Kolosova NG
    J Alzheimers Dis; 2010; 21(2):479-91. PubMed ID: 20555140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease-like pathology in senescence-accelerated OXYS rats can be partially retarded with mitochondria-targeted antioxidant SkQ1.
    Stefanova NA; Muraleva NA; Skulachev VP; Kolosova NG
    J Alzheimers Dis; 2014; 38(3):681-94. PubMed ID: 24047616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Cistanche deserticola on behavior and signs of cataract and retinopathy in senescence-accelerated OXYS rats.
    Stefanova NA; Fursova AZh; Sarsenbaev KN; Kolosova NG
    J Ethnopharmacol; 2011 Nov; 138(2):624-32. PubMed ID: 22020276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the mitochondria-targeted antioxidant SkQ1 on sexually motivated behavior in male rats.
    Amstislavskaya TG; Maslova LN; Gladkikh DV; Belousova II; Stefanova NA; Kolosova NG
    Pharmacol Biochem Behav; 2010 Aug; 96(2):211-6. PubMed ID: 20470816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Antioxidant SkQ1 on Accumulation of Mitochondrial DNA Deletions in the Hippocampus of Senescence-Accelerated OXYS Rats.
    Loshchenova PS; Sinitsyna OI; Fedoseeva LA; Stefanova NA; Kolosova NG
    Biochemistry (Mosc); 2015 May; 80(5):596-603. PubMed ID: 26071779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic action of the mitochondria-targeted antioxidant SkQ1 on retinopathy in OXYS rats linked with improvement of VEGF and PEDF gene expression.
    Markovets AM; Fursova AZ; Kolosova NG
    PLoS One; 2011; 6(7):e21682. PubMed ID: 21750722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant SkQ1 Alleviates Signs of Alzheimer's Disease-like Pathology in Old OXYS Rats by Reversing Mitochondrial Deterioration.
    Kolosova NG; Tyumentsev MA; Muraleva NA; Kiseleva E; Vitovtov AO; Stefanova NA
    Curr Alzheimer Res; 2017; 14(12):1283-1292. PubMed ID: 28637402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of behavioural dysfunctions in accelerated-senescence OXYS rats is associated with early postnatal alterations in brain phosphate metabolism.
    Sergeeva S; Bagryanskaya E; Korbolina E; Kolosova N
    Exp Gerontol; 2006 Feb; 41(2):141-50. PubMed ID: 16310999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of Alzheimer's Disease-Like Pathology Progression by Mitochondria-Targeted Antioxidant SkQ1: A Transcriptome Profiling Study.
    Stefanova NA; Ershov NI; Kolosova NG
    Oxid Med Cell Longev; 2019; 2019():3984906. PubMed ID: 31396299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mitochondria-targeted antioxidant SkQ1 restores αB-crystallin expression and protects against AMD-like retinopathy in OXYS rats.
    Muraleva NA; Kozhevnikova OS; Zhdankina AA; Stefanova NA; Karamysheva TV; Fursova AZ; Kolosova NG
    Cell Cycle; 2014; 13(22):3499-505. PubMed ID: 25483086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria-targeted antioxidant SkQ1 inhibits age-dependent involution of the thymus in normal and senescence-prone rats.
    Obukhova LA; Skulachev VP; Kolosova NG
    Aging (Albany NY); 2009 Apr; 1(4):389-401. PubMed ID: 20195490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An attempt to prevent senescence: a mitochondrial approach.
    Skulachev VP; Anisimov VN; Antonenko YN; Bakeeva LE; Chernyak BV; Erichev VP; Filenko OF; Kalinina NI; Kapelko VI; Kolosova NG; Kopnin BP; Korshunova GA; Lichinitser MR; Obukhova LA; Pasyukova EG; Pisarenko OI; Roginsky VA; Ruuge EK; Senin II; Severina II; Skulachev MV; Spivak IM; Tashlitsky VN; Tkachuk VA; Vyssokikh MY; Yaguzhinsky LS; Zorov DB
    Biochim Biophys Acta; 2009 May; 1787(5):437-61. PubMed ID: 19159610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive oxygen species produced in mitochondria are involved in age-dependent changes of hematopoietic and mesenchymal progenitor cells in mice. A study with the novel mitochondria-targeted antioxidant SkQ1.
    Shipounova IN; Svinareva DA; Petrova TV; Lyamzaev KG; Chernyak BV; Drize NI; Skulachev VP
    Mech Ageing Dev; 2010 Jun; 131(6):415-21. PubMed ID: 20600239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ameliorative effects of SkQ1 eye drops on cataractogenesis in senescence-accelerated OXYS rats.
    Rumyantseva YV; Ryabchikova EI; Fursova AZ; Kolosova NG
    Graefes Arch Clin Exp Ophthalmol; 2015 Feb; 253(2):237-48. PubMed ID: 25267419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SkQ1 slows development of age-dependent destructive processes in retina and vascular layer of eyes of wistar and OXYS rats.
    Saprunova VB; Lelekova MA; Kolosova NG; Bakeeva LE
    Biochemistry (Mosc); 2012 Jun; 77(6):648-58. PubMed ID: 22817465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of CREB by St. John's wort may diminish deletorious effects of aging on spatial memory.
    Trofimiuk E; Holownia A; Braszko JJ
    Arch Pharm Res; 2010 Mar; 33(3):469-77. PubMed ID: 20361314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term antioxidant supplementation attenuates oxidative stress markers and cognitive deficits in senescent-accelerated OXYS rats.
    Kolosova NG; Shcheglova TV; Sergeeva SV; Loskutova LV
    Neurobiol Aging; 2006 Sep; 27(9):1289-97. PubMed ID: 16246464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals.
    Neroev VV; Archipova MM; Bakeeva LE; Fursova AZh; Grigorian EN; Grishanova AY; Iomdina EN; Ivashchenko ZhN; Katargina LA; Khoroshilova-Maslova IP; Kilina OV; Kolosova NG; Kopenkin EP; Korshunov SS; Kovaleva NA; Novikova YP; Philippov PP; Pilipenko DI; Robustova OV; Saprunova VB; Senin II; Skulachev MV; Sotnikova LF; Stefanova NA; Tikhomirova NK; Tsapenko IV; Shchipanova AI; Zinovkin RA; Skulachev VP
    Biochemistry (Mosc); 2008 Dec; 73(12):1317-28. PubMed ID: 19120017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoprotective Effect of SkQ1, Visomitin Eye Drops, Is Associated with Suppression of P38 MAPK and ERK1/2 Signaling Pathways Activity.
    Muraleva NA; Zhdankina AA; Fursova AZ; Kolosova NG
    Biochemistry (Mosc); 2024 Feb; 89(2):201-211. PubMed ID: 38622090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Mitochondrial Antioxidant Plastoquinonyl-decyl-triphenylphosphonium Bromide (SkQ1) in the Rat Model of Autoimmune Arthritis.
    Andreev-Andrievskiy AA; Kolosova NG; Stefanova NA; Lovat MV; Egorov MV; Manskikh VN; Zinovkin RA; Galkin II; Prikhodko AS; Skulachev MV; Lukashev AN
    Oxid Med Cell Longev; 2016; 2016():8703645. PubMed ID: 27293517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.